These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24091292)

  • 1. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
    Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
    Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.
    Qi J; Kan F; Ye X; Guo M; Zhang Y; Ren G; Li D
    Int Immunopharmacol; 2012 Dec; 14(4):770-8. PubMed ID: 23092552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
    Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
    Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.
    Li Q; Ren G; Xu L; Wang Q; Qi J; Wang W; Zhou B; Han X; Sun C; Wu Q; Yu Y; Peng Z; Zheng S; Li D
    Int Immunopharmacol; 2014 Jul; 21(1):119-27. PubMed ID: 24800661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.
    Lee JH; Cho ML; Kim JI; Moon YM; Oh HJ; Kim GT; Ryu S; Baek SH; Lee SH; Kim HY; Kim SI
    J Rheumatol; 2009 Apr; 36(4):684-92. PubMed ID: 19228664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
    Lee SW; Kim JH; Park MC; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(4):260-8. PubMed ID: 18612926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway.
    Yu Y; Li S; Liu Y; Tian G; Yuan Q; Bai F; Wang W; Zhang Z; Ren G; Zhang Y; Li D
    Int Immunopharmacol; 2015 Mar; 25(1):74-82. PubMed ID: 25601498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
    Magari K; Miyata S; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrroloquinoline Quinone Decelerates Rheumatoid Arthritis Progression by Inhibiting Inflammatory Responses and Joint Destruction via Modulating NF-κB and MAPK Pathways.
    Liu Z; Sun C; Tao R; Xu X; Xu L; Cheng H; Wang Y; Zhang D
    Inflammation; 2016 Feb; 39(1):248-256. PubMed ID: 26319019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
    Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
    MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis.
    Wang Y; Wu Q; Liu Z; Guo X; Zhou L; Wang Y; Song L; Wang N; Zheng Q; Wang W; Ren G; Li D
    Biomed Pharmacother; 2017 May; 89():426-437. PubMed ID: 28249243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.